What's new? Log in Free sign up

Regencell Bioscience Holdings Limited (RGC)

Company Profile

Company profile

Ticker

RGC

Exchange

Website

www.regencellbioscience.com

CEO

Mr. Yat-Gai Au

Incorporated

Location

Fiscal year end

Industry (SIC)

Medicinal Chemicals & Botanical Products

Curaleaf • Ayr Wellness • Jushi • Ascend Wellness • Trulieve Cannabis • USANA Health Sciences • 4Front Ventures • SNDL • Mind Medicine • Glass House Brands ...

Former names

Edible Garden Inc

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

RGC stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Annual report (foreign)

25 Oct 24

Regencell Bioscience Holdings Limited Announces First Half 2024 Financial Results

Report of Foreign Private Issuer

Form of Letter of Lock-up Undertaking

Annual report (foreign)

27 Oct 23

Regencell Bioscience Holdings Limited Announces First Half 2023 Management Financial Results

SECOND EXTENSION OF letter of Lock-Up Undertaking

Report of Foreign Private Issuer

Report of Foreign Private Issuer

Report of Foreign Private Issuer

Latest ownership filings

Regencell (BVI) Ltd

Regencell (BVI) Ltd

Regencell (BVI) Ltd

Regencell (BVI) Ltd

Digital Mobile Venture Ltd.

Regencell (BVI) Ltd

Regencell (BVI) Ltd

Financial summary

Financial statements Chart RGC financial data

Quarter (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2023

RGC institutional ownership history Ownership history

88.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4	5	-20.0%
Opened positions	1	1	–
Closed positions	2	1	+100.0%
Increased positions	0	0
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	355.93 mm	350.43 mm	+1.6%
Total shares	11.55 mm	11.55 mm	+0.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Regencell (BVI)	10.56 mm	$333.85 mm	0.0%
Digital Mobile Venture	988.90 k	$10.38 mm	0.0%
MS Morgan Stanley	301.00	$6.53 mm	NEW
BLK BlackRock	238.00	$5.17 mm	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
MS Morgan Stanley	301.00	+301.00	NEW
Tower Research Capital	0.00	-200.00	EXIT
UBS UBS	0.00	-1.00	EXIT
Proequities	0.00	0.00
BLK BlackRock	238.00	0.00	0.0%
Digital Mobile Venture	988.90 k	0.00	0.0%
Regencell (BVI)	10.56 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

12 Health Care Stocks Moving In Monday's Intraday Session

On Friday October 25, 2024 Regencell Bioscience Reported FY24 EPS $(0.33) Up From $(0.45) YoY

Regencell Bioscience (NASDAQ:RGC) reported quarterly losses of $(0.33) per share. This is a 26.67 percent increase over losses of $(0.45) per share from the same period last year.

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.